What Should Specialty Pharmacists Know About the ReDOS Clinical Trial?

Tanios Bekaii-Saab, MD, FACP, Mayo Clinic Cancer Center, talks about key takeaways from the phase 2 ReDOS clinical trial for specialty pharmacists.